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Antibiotic therapy in response to Mycobacterium
tuberculosis infections targets de novo fatty acid
biosynthesis, which is orchestrated by a 1.9 MDa
type I fatty acid synthase (FAS). Here,wecharacterize
M. tuberculosis FAS by single-particle cryo-electron
microscopy and interpret the data by docking the
molecular models of yeast and Mycobacterium
smegmatis FAS. Our analysis reveals a porous
barrel-like structure of considerable conformational
variability that is illustrated by the identification of
several conformational states with altered topology
in the multienzymatic assembly. This demonstrates
that the barrel-like structure of M. tuberculosis FAS
is not just a static scaffold for the catalytic domains,
but may play an active role in coordinating fatty acid
synthesis. The conception of M. tuberculosis FAS
as a highly dynamic assembly of domains revises
the view on bacterial type I fatty acid synthesis and
might inspire new strategies for inhibition of de
novo fatty acid synthesis inM. tuberculosis.
INTRODUCTION
Mycobacterium tuberculosis is the causative agent of tubercu-
losis (TB), and interest in its lipid metabolism is driven by its
high medicinal relevance. For example, the lipid, mycolic acid,
is a major component of the cell wall, which creates an efficient
barrier due to its low permeability and fluidity and is largely
regarded as being responsible for the intrinsic resistance of
M. tuberculosis to dehydration and chemical treatment. In
M. tuberculosis, lipid biosynthesis is carried out in part by a large
(1.9 MDa) homohexameric complex termed the type I fatty acid
synthase (FAS). Functional studies have characterized
M. tuberculosis FAS as producing de novo C16- and C26-fatty
acids (Kikuchi et al., 1992). Subsequently, partly modified C60-
to C90-mycolic acids are synthesized by a type II fatty acidStructure 21, 1synthase mediated elongation of the C16 precursors to up to
C56-meromycolic acid that are then further condensed with
C26-fatty acids (Portevin et al., 2004). Covalently attached to
arabinogalactan and trehalose, mycolic acids build the myco-
bacterial cell wall (Bhatt et al., 2007; Hoffmann et al., 2008).
M. tuberculosis FAS has been shown to be essential (Lamich-
hane et al., 2003; Sassetti et al., 2003), and, interestingly, the
occurrence of type I fatty acid synthesis in bacteria correlates
with mycolic acid biosynthesis (Gago et al., 2011). The relevance
of themycolic acid based cell wall forM. tuberculosis cell growth
and survival is manifested in the use of three inhibitors of its
biosynthesis, pyrazinamide, isoniazid, and ethambutol, in antibi-
otic therapy for TB (Ma et al., 2010), of which pyrazinamide has
been identified as specifically targeting M. tuberculosis FAS
(Sayahi et al., 2011; Zimhony et al., 2000). Facing a resurgence
of TB and the increasing number of multidrug and extremely
drug-resistant TB strains, the World Health Organization
launched the Stop TB Strategy in 2006 with the aim to improve
current and develop new treatment regimens (Koul et al., 2011;
Lo¨nnroth et al., 2010).
Recently, the bacterial type I FAS was characterized at 7.5 A˚
resolution while assuming D3 symmetry, showing a homohex-
amer in a conformation similar to the one adopted by the fungal
FAS (Boehringer et al., 2013).M. tuberculosis FAS has not been
structurally analyzed to date and in our program to establish
and improve type I FAS systems as targets for rational drug
design (Johansson et al., 2008), we have developed protocols
for recombinant expression and purification of type I FAS sys-
tems. Here, we report the three-dimensional cryo-electron
microscopic (cryo-EM) characterization of the M. tuberculosis
FAS purified as a recombinant protein from the expression host
Escherichia coli. Furthermore, we employed computational sort-
ing combined with a symmetry-free refinement to demonstrate
that the individual subunits of the 1.9 MDa bacterial type I FAS
have significant conformational variability. Overall, our maps
reproduce features seen in the higher resolution model of the
Mycobacterium smegmatis FAS (Boehringer et al., 2013) and
support the conclusions that bacterial FAS is aminimized version
of fungal FAS lacking significant structural domains. Further-
more, fitting the M. smegmatis FAS model (Boehringer et al.,
2013) into our maps facilitates interpretation of the observed251–1257, July 2, 2013 ª2013 Elsevier Ltd All rights reserved 1251
Figure 1. Analysis and Overall Structure of M. tuberculosis FAS
(A) Coomassie-stained SDS gel of purified M. tuberculosis (M.tub) and C. ammoniagenes FAS (C.amm).
(B) Size exclusion chromatography ofM. tuberculosis (solid line) andC. ammoniagenes FAS (dashed line). The peaks correspond to an apparent molecular weight
of 1.5 MDa (o), 1.3 MDa (x), and 600 kDa (D). The inset shows a calibration curve with reference proteins S. cerevisiae FAS (S.cer), thyroglobulin (tg), ferritin (ft),
aldolase (ald), and conalbumin (ca).M. tuberculosis (h, hexameric state; d, dimeric) andC. ammoniagenes FAS are plotted according to their calculatedmolecular
weights and elution volumes. See also Figure S1.
(C) Cryo-EM class averages ofM. tuberculosis and S. cerevisiae FAS. Each class contains 50 projections, except for the top view of fungal FAS (five projections),
which is rarely observed in vitreous ice.
(D–F) Reconstructions with resolutions of 17.5 A˚, 20.2 A˚, and 27.0 A˚, respectively in side and top view. See also Figure S2.
(G–I) MAT positions P1 (G), P2 (H), and P3 (I). The domains (KS, ketoacyl synthase; KR, ketoacyl reductase; DH, dehydratase; ER, enoyl reductase; AT, acetyl
transferase; MAT, malonyl-acyl-transferase) in each chain in bacterial FAS are distinctly colored and denoted with a superscript. Note that the MAT domain is
homologous to the malonyl-palmitoyl-transferase (MPT) domain in fungal FAS, but denoted MAT due to its substrate specificity for malonyl-CoA as well as acyl
CoAs of different chain length.
See also Movies S1, S2, and S3.
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Structure of the Bacterial Fatty Acid Megasynthaseconformational changes and indicates that individual MAT do-
mains adopt several conformations within the homohexamer.
These results, therefore, suggest that we should revise the
current conception that the bacterial type I FAS is a rigid multi-
enzyme complex and consider that it may undergo significant
structural rearrangements during fatty acid synthesis that con-
tribute to the protein-channeled substrate shuttling mechanism.
RESULTS
Biochemical Characterization of Recombinantly
Expressed M. tuberculosis FAS
M. tuberculosis is a highly pathogenic organism, which hampers
direct access to proteins from native preparations. To gain
insight into the structure of M. tuberculosis FAS, we therefore
achieved recombinant access in a similar way as it has been1252 Structure 21, 1251–1257, July 2, 2013 ª2013 Elsevier Ltd All rigreported for the homologous Corynebacterium ammoniagenes
FAS (Stuible et al., 1997). Because of its well-characterized
recombinant expression, purification, and subsequent activity
profile, C. ammoniagenes FAS was also chosen as a reference
in M. tuberculosis FAS preparations (Stuible et al., 1997).
M. tuberculosis FAS was expressed as a soluble protein in
Escherichia coli and purified in a two-step chromatographic pro-
tocol (Figure 1A). The protein eluted as a mixture of dimer (Kiku-
chi et al., 1992) and hexamer, as estimated by comparison with
reference proteins (Figure 1B). For cryo-EM structural character-
ization of fungal FAS (Gipson et al., 2010), we had treated
the natively purified protein by synchronization/inhibition
protocols to avoid conformational heterogeneity of its six
reactions centers induced by undefined substrate loading.
In a similar strategy, and as an opportunity given by our
recombinant expression strategy, we decided to work withhts reserved
Structure
Structure of the Bacterial Fatty Acid Megasynthasenonposttranslationally phosphopantetheinylated and, thus,
nonactivated M. tuberculosis FAS. Characterization of the
recombinantly expressed M. tuberculosis ACP domain as a
separate protein confirmed the absence of the posttranslational
modification and supported the inability of the E. coli host to
activateM. tuberculosis FAS under the selected expression con-
ditions (Figure S1 available online; see also Experimental Proce-
dures and Supplemental Experimental Procedures).
Initial electron microscopic studies of purified M. tuberculosis
FAS, in both its dimeric (Kikuchi et al., 1992) and hexameric form,
indicated that the dimer does not show a distinct conformation,
whereas the hexamer appears to have a barrel-like structure with
D3 symmetry similar to fungal FAS (Figure 1C). These images of
the hexamer, therefore, agree with (1) earlier electron micro-
scopic studies on the homologous C. ammoniagenes FAS,
which indicated that the bacterial FAS type I possesses a bar-
rel-like structure (Morishima et al., 1982), (2) protein sequence
analysis implying the conservation of the fungal FAS multido-
main structure (Jenni et al., 2007), and (3) the recent 3D-EM
reconstruction of M. smegmatis FAS type I (Boehringer et al.,
2013).
Single Particle Cryo-EM Analysis ofM. tuberculosis FAS
Initially, we determined the 3D structure ofM. tuberculosis FAS,
while imposing D3 symmetry, however, despite the fact that our
data set consisted of 100,000 projections of the asymmetric
unit, this initial reconstruction never significantly progressed
in terms of resolution. Accordingly, we refined the structure
without imposing symmetry while sorting the data set through
the use of codimensional principal component analysis
(CD-PCA) (Penczek et al., 2011) followed by multireference
refinement and subsequently noticed that at least one of the
protein chains composing the homohexamer was in a distinct
conformation. It should also be noted that studies on the
chaperonin TRiC (Cong et al., 2012) and GroEL (Clare et al.,
2012) were similarly able to identify conformational changes
within structures previously assumed to display higher order
symmetry.
This symmetry-free approach yielded three distinguishable
and interpretable EM maps containing 16,830 particle projec-
tions (Figures 1D–1F) from the final data set of 22,730 projec-
tions. The resulting reconstructions have a resolution of
17.5 A˚ (map 1), 20.2 A˚ (map 2), and 27.0 A˚ (map 3) (Figure S2)
according to the 0.5 FSC criterion (Bo¨ttcher et al., 1997; Harauz
and van Heel, 1986). For analysis, we focus primarily on map 1
(Figure 1D), as it has the highest resolution. Map 3 displays the
lowest resolution with the weakest (most fragmented) densities
in the domes suggesting it is still conformationally flexible, but
given the small number of projections corresponding to this
volume, we could not attempt further classification. Therefore,
due to its lower reliability, map 3 is largely excluded from
discussion.
M. tuberculosis FAS Lacks Scaffolding Elements
of Eukaryotic Homologs
In M. tuberculosis FAS, all the catalytic domains necessary for
fatty acid synthesis are carried on a singe polypeptide chain
with a molecular weight of 327 kDa, unlike the hetero-dodeca-
meric fungal FAS where the catalytic domains, including theStructure 21, 1phosphopantetheine transferase (PPT), are distributed among
two polypeptides of 207 kDa (a chain) and 229 kDa (b chain) (Fig-
ure S3). Despite this difference, the cryo-EM reconstructions
reveal that the homohexamericM. tuberculosis FAS has a fungal
FAS-like barrel structure where a central wheel is capped by hol-
low domes on each side (Jenni et al., 2007; Johansson et al.,
2008; Leibundgut et al., 2007; Lomakin et al., 2007) (Figures
1D–1F). In fungal FAS, 50% of the protein has a purely structural
role that provides an architectural scaffolding to the complex and
this contrastsM. tuberculosis FAS where the scaffolding consti-
tutes just 35% of the protein (Figure 2A). To localize structural
elements that are absent in M. tuberculosis FAS, we fitted the
fungal FAS crystal structure to the cryo-EM reconstructions
and identified elements for which no structural homologwas pre-
sent inM. tuberculosis FAS, namely the nonconserved elements
protruding from the density (Figure 2B). This analysis shows that
in the equatorial wheel of M. tuberculosis FAS the so-called
dimerization modules, DM2 and DM4 in fungal FAS, are missing
(Figure 2B). However, their absence eliminates peripheral exten-
sions of existing interfaces, and, therefore, would not likely
destabilize the complex (Figure 2B). In contrast, in the domes
of M. tuberculosis FAS entire interaction surfaces are missing.
In fungal FAS, three contacts between the wheel and dome
were found and defined C1, C2, and C3 (Jenni et al., 2007), of
which only C1 appears largely unaltered in M. tuberculosis
FAS. In fungal FAS, C2 is mediated by the hotdog domain
2 (HDD2) and a long a helix linking the KR and KS domains
that protrudes from the central wheel. The map of
M. tuberculosis FAS indicates that HDD2 is missing and the
long a helix is considerably shortened, eliminating C2 entirely
and opening up a large window on the side of the dome (window
1; Figure 2C). In fungal FAS, C3 connects the MPT domain (the
fungal equivalent to theM. tuberculosisMAT domain) to the cen-
tral wheel (KR) and is mediated by a hairpin-like fold (Jenni et al.,
2007). In Figure 2C, it can be seen that these secondary structure
elements protrude from the map and are, therefore, likely
missing in the M. tuberculosis FAS structure. In fact, sequence
alignments suggest that they are absent in bacterial FAS sys-
tems in general (Jenni et al., 2007; Boehringer et al., 2013). How-
ever, we see a fusion of density in the maps between the
domains MAT and KR (Figure 2C) indicating that, despite the
absence of the hairpin-like fold, an interaction likely exists. In
agreement, the recent cryo-EM structure of the homologous
M. smegmatis FAS confirms the absence of these secondary
structure elements, but similarly suggests a minimal interaction
interface considerably smaller than the C3-contact in fungal
FAS (Jenni et al., 2007). Finally, the complete absence of the
N-terminal trimerization domain (TD) that is found in fungal FAS
results in M. tuberculosis FAS having an open top (window 2;
Figure 2D).
The MAT Domain Is Observed in Different Positions
In contrast to previous work, which treated bacterial and fungal
FAS (Gipson et al., 2010, Boehringer et al., 2013) as particles
with D3 symmetry, our symmetry-free analysis is able to detect
differences in the individual chains of the FAS particle. This is
particularly evident when map 1 and 2 are compared (Movie
S1). To understand the conformational changes in our maps,
we have fitted the model of M. smegmatis FAS (Boehringer251–1257, July 2, 2013 ª2013 Elsevier Ltd All rights reserved 1253
Figure 2. Domain Arrangement of
M. tuberculosis FAS and Structural
Differences to Fungal FAS
(A) Protein structure of M. tuberculosis FAS in
comparison with fungal FAS. Catalytic domains
are shown in light gray, insertions connecting the
catalytic domains and used for scaffolding in dark
gray. Red bars indicate scaffolding elements, the
trimerization domain (TD) and PPT domain of
fungal FAS that are absent inM. tuberculosis FAS.
Domains forming the dome and central wheel are
indicated; the ACP is attached via flexible linkers
to the MAT domain and the central hub. See also
Figure S3.
(B) A top view corresponding to a central section of
map 1 fitted with the fungal FAS structure (red,
2UV8) showing that, with the exception of the
dimerization modules DM2 and DM4, most struc-
tural features of the central wheel are conserved
between bacterial and fungal FAS.
(C) Zoom at contacts C2 and C3 of fungal FAS
absent in M. tuberculosis FAS.
(D) A top viewofmap1 showing the largewindow2,
which in fungal FAS is closed by the N-terminal TD.
For the homology model of M. smegmatis FAS
fitted intoM. tuberculosismaps see Figures S4–S6.
Structure
Structure of the Bacterial Fatty Acid Megasynthaseet al., 2013) to maps 1 and 2. The model could be fitted to map 2
largely without modification (Figure S4). This was different for
map 1, where the domains MAT and DH of a single chain had
to be fitted independently to correctly position the complete
model of M. smegmatis FAS in map1 (Figure S5). It is important
to note that the fitting shows that our maps reproduce features
expected of a 17–20 A˚ map, namely the contours of the domains
(see Figures S4 and S5). Therefore, when the maps are
compared, it is evident that the most prominent difference
between them lies in the positioning of the MAT domain. This
domain is most commonly observed in a position designated
P2 that can generally be described as interacting with the KR
domain of a neighboring FAS chain (Figure 1H). The P2 position
of the MAT domain is very similar to that observed in the
M. smegmatis FAS and fungal FAS structures (Jenni et al.,
2007; Johansson et al., 2008; Leibundgut et al., 2007; Lomakin
et al., 2007; Boehringer et al., 2013). In contrast, the indepen-
dently fitted MAT domain in map 1 (Figure S5) occupies a posi-
tion roughly shifted by 20 A˚ relative to that observed in the1254 Structure 21, 1251–1257, July 2, 2013 ª2013 Elsevier Ltd All rights reservedM. smegmatis FAS model, such that it is
in a position we designate P3 (Figure 1I).
Here, the MAT domain shifts to interact
at the interface between its own KR
domain and that of the neighboring chain.
This shift requires a concomitant move-
ment of the DH domain such that
together they appear to pivot around the
ER domain (Figure S6; Movie S2). Map
1 indicates that, when the MAT domain
is in the P3 position, the density for the
neighboring AT domain (AT00) becomes
weaker and discontinuous with the
MAT/DH domains (Figure 1I), suggestingthat the interface is disrupted and the AT00 domain is flexible.
This also opens the reaction chamber, making it highly acces-
sible to the outside environment (Movie S3). An alternative posi-
tioning of the MAT domain, designated P1 (Figure 1G), is also
observed in map 3. In order to allow the MAT domain to achieve
this position, the ER domain of the same subunit needs to bend
inward. Thus, MAT moves closer to the KR and KS of a neigh-
boring chain of the opposite dome (KR0, KS0) and to the KS
and ER domains of the other neighboring chain (ER00, KS00).
The resolution of the map does unfortunately not allow us to
define this interaction in more detail. Flexibility in the interface
formed between the MAT domain and the central wheel of
M. tuberculosis FAS likely results from the formation of a consid-
erably smaller interface between the MAT and KR domain than
seen in fungal FAS (Jenni et al., 2007). Moreover the absence of
the HDD2 domain and shortening of the a helix linking KS and
KR (Figure 2C) may confer increased flexibility to the DH
domain. The overall shift of the MAT domain from P3 to P1
position is 40 A˚.
Structure
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Dynamic Reorganization of Domain Assembly during
M. tuberculosis FAS-Mediated Fatty Acid Synthesis
In a global view of fatty acid synthase type I systems, fungal and
mammalian FAS are contrasting solutions for substrate shuttled
multienzyme fatty acid synthases. The fungal protein arranges
the catalytic domain in an extensive structural scaffold provided
by 50%of amino acids (Jenni et al., 2007; Johansson et al., 2008;
Leibundgut et al., 2007; Lomakin et al., 2007; Maier et al., 2008)
and rigidly embeds enzymatic domains, which are approached
by amobile ACP shuttling substrates and intermediates between
active sites. Themammalian FAS is poorly interspersed by struc-
tural adaptors comprising only 10% of the polypeptide chain
(Maier et al., 2008). This results in a less conformationally con-
strained framework in which mobile catalytic domains collabo-
rate with the mobile ACP for fatty acid synthetic progress
(Brignole et al., 2009; Rangan et al., 2001). The decrease of the
structural framework to 35%, compared to 50% in the structur-
ally related fungal FAS, confers the observed structural variability
seen in M. tuberculosis FAS. Importantly, our data revise the
conception of bacterial type I FAS as a rigid multienzyme
complex based on its homology to fungal FAS. The local lower
resolution of MAT domains recently found in cryo-EM recon-
structions indicate similar conformational flexibility in the homol-
ogous FAS ofM. smegmatis (Boehringer et al., 2013), supporting
this view. Our data, moreover, suggest that bacterial type I FAS
represents, conceptually, a third solution to fatty acid synthesis.
The working mode of M. tuberculosis FAS, i.e., a mobile ACP
moving within an overall moderately flexible protein complex,
does not lie between the concepts of substrate shuttling realized
by the fungal (mobile ACP within a rigid complex) and the
mammalian FAS (mobile ACP within a highly flexible complex).
Rather, as highlighted by the mobility of the MAT domain and
the breakage and reformation of the AT-DH interchain contact,
it is different to both of these systems, as it includes a dynamic
reorganization of the domain-domain interactions within the cat-
alytic body of the multienzyme (Figures 1G–1I; Movie S3).
Although the presented data are at too low resolution to claim
relevance for structure-based drug design, we consider the
characterization of this protein as a highly dynamic assembly
of domains as relevant to antituberculosis inhibition strategies:
for example, initiating the development of new inhibitory con-
cepts based on the conformational flexibility of individual
domains.
General Concept of the Bacterial Type I FAS
The homology of M. tuberculosis FAS to fungal FAS and the
narrow phylogenetic distribution of M. tuberculosis FAS-like
type I systems in bacteria (in the genera Mycobacterium and
Corynebacterium) indicate that bacterial type I FAS either
evolved by an evolutionarily early horizontal gene transfer from
fungi, or that bacterial type I FAS represent an ancient minimal
type I FAS which further developed in fungi and just kept pre-
served in mycolic acid producing bacteria. Independent of the
scenario, our data raise the question whether the absence of
noncatalytic scaffolding elements in bacterial FAS results in
particular functions/activities, or serves a general purpose of
genome reduction (Brocchieri and Karlin, 2005; Mira et al.,Structure 21, 12001). In this regard, the structural reduction of bacterial FAS
may influence its activity in the following ways. First, the more
porous structure as compared to fungal FAS could allow macro-
molecules to access the inner reaction chambers changing the
environment and contributing to molecular crowding effects
(Anselmi et al., 2010). Previous studies have shown that polysac-
charides influence the mycobacterial type I FAS activity and the
product spectrum (Brindley et al., 1969; Zimhony et al., 2004).
Second, as the domains MAT and ACP are physically linked,
the observed flexibility of the MAT (Figures 1G–1I) will directly
influence the trajectory of the ACP during substrate shuttling,
which could confer programming to the substrate shuttling
mechanism (Anselmi et al., 2010; Gipson et al., 2010; Leibundgut
et al., 2007). The influence of the MAT domain on the ACP may
even be amplified, as sequence alignments suggest that the
flexible linker connecting the ACP and MAT domains in
M. tuberculosis FAS is approximately nine amino acids shorter
than in S. cerevisiae FAS. In agreement with this, it is known
that in mammalian FAS changes to the linker connecting the
product releasing thioesterase domain (TE) and ACP alter
the length of synthesized fatty acids (Joshi et al., 2005). Third,
the observed conformational changes in M. tuberculosis FAS
change the structure of the domes and most likely influence
surface properties of the inner reaction chambers. It has been
suggested that electrostatic complementarity at active sites
facilitates ACP recognition (Gipson et al., 2010; Johansson
et al., 2009; Leibundgut et al., 2007; Lomakin et al., 2007; Rafi
et al., 2006). Specifically, molecular dynamics calculations
have indicated that the surface properties of the reaction cham-
bers affect the residence time of the ACP in the vicinity of cata-
lytic sites (Anselmi et al., 2010). Therefore, variability in dome
conformations can potentially impose a higher-order concept
of protein-channeled substrate shuttling in M. tuberculosis FAS
and bacterial type I FAS in general.
EXPERIMENTAL PROCEDURES
Recombinant Expression and Purification ofM. tuberculosis FAS
We PCR-amplified the M. tuberculosis FAS coding sequence Rv2524c from
the plasmid pYUB956. By ligation-free methods, the 9.2 kb gene was cloned
into a pET22b(+)-based plasmid under the control of an IPTG-inducible T7 pro-
moter yielding plasmid pME200.M. tuberculosis FAS was expressed as a sol-
uble protein in E. coli BL21(DE3) and purified by affinity chromatography using
an N-terminal strepII tag (Schmidt and Skerra, 2007) and size exclusion chro-
matography (Figures 1A and 1B).
Sample Preparation and Electron Cryo-EM
The samples were applied to glow-discharged Quantifoil grids and plunge-
frozen in liquid ethane with a FEI Vitrobot. Images were collected on SO-163
film on a Tecnai G2 Polara electron microscope operating at 200 kV at a defo-
cus range of 1.8 to 4.5 mm and an electron dose of 18 e/A˚2. The negatives
were digitized on a Zeiss Photoscan scanner (Intergraph) with a step size of
1.14 A˚ at the specimen.
Data Processing
The EMAN2 image processing software was used to box out particles, deter-
mine and correct theCTF (Tang et al., 2007), and obtain an initial reconstruction
imposingD3 symmetry. Three-dimensional refinement did not improve the res-
olution of themap beyond 18 A˚ (0.5 FSC criterion), suggesting heterogeneity in
the data set. The source of this heterogeneity was explored by releasing the
symmetry and sorting the data set using CD-PCA (Penczek et al., 2011) and
k-means clustering within the SPARX image-processing environment (Hohn251–1257, July 2, 2013 ª2013 Elsevier Ltd All rights reserved 1255
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Structure of the Bacterial Fatty Acid Megasynthaseet al., 2007). A total of 5,900 poorly aligning projections were removed from the
data set of 22,730, and finally three distinguishable and interpretable maps
were obtained that were used to seed a multireference refinement. The result-
ing reconstructions have a resolution of 17.5 A˚ (map 1, 9,136 projections),
20.2 A˚ (map 2, 4,337 projections), and 27.0 A˚ (map 3, 3,357 projections) ac-
cording to the 0.5 FSC criterion. Interpretation of the resulting maps was facil-
itated by fitting the yeast (Protein data Bank [PDB] 2UV8) and M. smegmatis
(PDB 4B3Yand 3ZEN) FAS structures (Boehringer et al., 2013) in the maps us-
ing simultaneous multifragment refinement of manual docking (COLLAGE)
approach within SITUS (Wriggers, 2010). Molecular graphics and analysis
was performed with the UCSF Chimera package (Pettersen et al., 2004).
ACCESSION NUMBERS
Maps were deposited to the EMDB with accession codes EMD-2357, EMD-
2358, and EMD-2359, and coordinates corresponding to the M. smegmatis
FAS homology model were deposited in the PDB with accession codes
4BJF and 4BJG (half 1 and 2) fitted to map EMD-2357 and 4BJD and 4BJE
(half 1 and 2) fitted to map EMD-2358.
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